Younger, premenopausal patients with breast cancer can have unique issues that providers need to keep in mind, said Denalee O’Malley, PhD, LSW, instructor, Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School.
Younger, premenopausal patients with breast cancer can have unique issues that providers need to keep in mind, said Denalee O’Malley, PhD, LSW, instructor, Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School.
Transcript
How can primary care doctors and oncologists collaborate to ensure that premenopausal patients with breast cancer have the necessary support to address the unique concerns of relationships, work, parenting, or other caregiving issues in a younger generation?
So, it’s important for the primary care physicians to get a report from the primary oncology team with both the treatments that patients have received and the anticipated late and long-term effects, as well as a surveillance plan. That’s currently called a cancer survivorship plan, and so, as a part of that plan [it designates] who’s going to be responsible for the different aspects of a patient’s care.
For younger breast cancer survivors, in particular, if there’s anticipated changes in menopausal status that would be helpful for primary care physicians to know. Also, who is going to be … the point person for symptoms management—so, if something comes up, does the patient know who to call, and how to get their needs met, is important for the navigational experience for the patient.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More